Indiana Trust & Investment Management CO Sells 535 Shares of The Procter & Gamble Company (NYSE:PG)

Indiana Trust & Investment Management CO decreased its position in The Procter & Gamble Company (NYSE:PGFree Report) by 4.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,872 shares of the company’s stock after selling 535 shares during the quarter. Procter & Gamble makes up approximately 0.8% of Indiana Trust & Investment Management CO’s portfolio, making the stock its 27th largest position. Indiana Trust & Investment Management CO’s holdings in Procter & Gamble were worth $1,926,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Norges Bank purchased a new stake in Procter & Gamble during the fourth quarter valued at about $3,956,117,000. Cerity Partners LLC lifted its holdings in shares of Procter & Gamble by 106.2% in the fourth quarter. Cerity Partners LLC now owns 6,134,455 shares of the company’s stock worth $898,943,000 after buying an additional 3,159,796 shares in the last quarter. Wellington Management Group LLP lifted its holdings in shares of Procter & Gamble by 9.4% in the third quarter. Wellington Management Group LLP now owns 35,608,913 shares of the company’s stock worth $5,193,916,000 after buying an additional 3,047,557 shares in the last quarter. International Assets Investment Management LLC lifted its holdings in shares of Procter & Gamble by 13,850.3% in the fourth quarter. International Assets Investment Management LLC now owns 2,747,379 shares of the company’s stock worth $402,601,000 after buying an additional 2,727,685 shares in the last quarter. Finally, Assenagon Asset Management S.A. lifted its holdings in shares of Procter & Gamble by 235.8% in the fourth quarter. Assenagon Asset Management S.A. now owns 3,231,032 shares of the company’s stock worth $473,475,000 after buying an additional 2,268,805 shares in the last quarter. Institutional investors own 65.77% of the company’s stock.

Procter & Gamble Stock Down 1.0 %

Shares of PG traded down $1.70 during midday trading on Friday, reaching $164.92. 9,164,345 shares of the stock were exchanged, compared to its average volume of 6,596,371. The Procter & Gamble Company has a 52 week low of $141.45 and a 52 week high of $169.41. The company has a current ratio of 0.69, a quick ratio of 0.48 and a debt-to-equity ratio of 0.49. The company’s 50 day moving average is $165.28 and its two-hundred day moving average is $158.54. The company has a market capitalization of $389.23 billion, a P/E ratio of 27.18, a PEG ratio of 3.40 and a beta of 0.42.

Procter & Gamble (NYSE:PGGet Free Report) last issued its quarterly earnings data on Friday, April 19th. The company reported $1.52 earnings per share for the quarter, topping analysts’ consensus estimates of $1.42 by $0.10. The firm had revenue of $20.20 billion during the quarter, compared to analysts’ expectations of $20.43 billion. Procter & Gamble had a return on equity of 33.91% and a net margin of 18.00%. The firm’s quarterly revenue was up .6% on a year-over-year basis. During the same period in the prior year, the business posted $1.37 EPS. On average, sell-side analysts anticipate that The Procter & Gamble Company will post 6.55 earnings per share for the current year.

Procter & Gamble Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th were paid a $1.0065 dividend. The ex-dividend date of this dividend was Thursday, April 18th. This is a boost from Procter & Gamble’s previous quarterly dividend of $0.94. This represents a $4.03 dividend on an annualized basis and a yield of 2.44%. Procter & Gamble’s dividend payout ratio (DPR) is 65.85%.

Insider Buying and Selling at Procter & Gamble

In other news, CEO Sundar G. Raman sold 31,924 shares of the stock in a transaction dated Monday, May 20th. The stock was sold at an average price of $166.95, for a total value of $5,329,711.80. Following the transaction, the chief executive officer now directly owns 19,042 shares of the company’s stock, valued at $3,179,061.90. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, insider Moses Victor Javier Aguilar sold 9,149 shares of the firm’s stock in a transaction dated Thursday, May 16th. The stock was sold at an average price of $167.72, for a total transaction of $1,534,470.28. Following the sale, the insider now directly owns 12,929 shares of the company’s stock, valued at $2,168,451.88. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CEO Sundar G. Raman sold 31,924 shares of the firm’s stock in a transaction dated Monday, May 20th. The stock was sold at an average price of $166.95, for a total value of $5,329,711.80. Following the sale, the chief executive officer now directly owns 19,042 shares in the company, valued at $3,179,061.90. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 154,544 shares of company stock worth $25,413,051. 0.17% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on the stock. StockNews.com raised shares of Procter & Gamble from a “hold” rating to a “buy” rating in a report on Tuesday. The Goldman Sachs Group initiated coverage on shares of Procter & Gamble in a research report on Friday, March 1st. They issued a “neutral” rating and a $168.00 price objective on the stock. BNP Paribas initiated coverage on shares of Procter & Gamble in a research report on Monday. They issued an “outperform” rating and a $187.00 price objective on the stock. Barclays upped their price objective on shares of Procter & Gamble from $168.00 to $170.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 23rd. Finally, Truist Financial upgraded shares of Procter & Gamble from a “hold” rating to a “buy” rating and upped their price objective for the stock from $160.00 to $175.00 in a research report on Monday, March 11th. Six research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. Based on data from MarketBeat, Procter & Gamble presently has a consensus rating of “Moderate Buy” and an average target price of $170.72.

Check Out Our Latest Research Report on PG

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

See Also

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.